JNCE   $1.88  -2.07% Market Closed

Jounce Therapeutics Inc
Total Cash 189.54M
totalCashPerShare 3.635
EBITDA -50.16M
Total Debt 10.02M
quickRatio 8.042
currentRatio 8.369
Total Revenue 82.00M
debtToEquity 5.472
Revenue/Share 1.587
ROA -0.14036
ROE -0.25027
grossProfits 27.20M
freeCashflow -12.42M
operatingCashflow -28.88M
earningsGrowth
revenueGrowth
grossMargins 0.33166
ebitdaMargins -0.61165
operatingMargins -0.6371
profitMargins -0.62096
enterpriseValue -81.50M
forwardPE -1.8252428
floatShares 29.81M
sharesOutstanding 52.64M
sharesShort 2.02M
sharesShortPriorMonth 3.18M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.85%
Short Ratio help_outline 0.48%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 3.542
Price To Book help_outline 0.53
earningsQuarterlyGrowth
netIncomeToCommon -50.92M
trailingEps -0.96%
forwardEps -1.03%
enterpriseToEbitda 1.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.68 1Q 2023
institutionsCount 123
lastUpdated July 1, 2023, 2:34 p.m.